SAGE-718

· Supernus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for SAGE-718, covering 2023-06-06 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease [Phase 3]